Dr. Nikolaus Raupp
Principal
About me
| Team | Life Sciences & Chemistry |
| at HTGF since | 2021 |
CV
Nik has always been fascinated by the challenges how to finance an innovative start-up company. While researching for his PHD about financing of biotech companies in Japan, Nik started working as a consultant and later as project manager for a German-Japanese biotech pharma partnering project.
In 2011 Nik has joint BASF. With different roles in BASF, he has gained extensive experience in the field of sustainable innovation, renewable raw materials and climate protection. Since 2018 Nik has worked as a senior marketing manager for BASF in Hong Kong. He has initiated and launched several new solutions for customers in China, Japan, India and Australia.
In April 2021, Nik has joint the life science team as Investment Manager with a special focus on the chemical industry.
My success stories in the HTGF portfolio
ai-predict has developed a software platform that calculates the properties of a product. For our customers in the specialty chemicals industry, existing customer data (e.g. formulations and laboratory data) is …
To the complete profileof ai-predict
O11 biomedical, a visionary medical technology start-up that emerged as part of BioTex at RWTH Aachen University/ University Hospital Aachen 2022, aims to improve survival rates and quality of life …
To the complete profileof O11 biomedical
Hamburg-based COLIPI is developing an industrial biotechnological process that transforms climate-damaging CO2 and carbon-containing industrial waste into Climate Oil. This product serves as a sustainable and climate-neutral alternative to palm …
To the complete profileof COLIPI
PlastFormance develops, produces and markets unique polymer compounds for high-tech applications. The patented PlastFormance technology makes it possible to incorporate unprecedented amounts of ceramic and metallic fillers into a wide …
To the complete profileof PlastFormance
hema.to is an easy-to-use software for clinical decision support for blood cancer from cytometry data using AI. hema.to makes the diagnostic workflow both faster and better, helping both diagnosticians as …
To the complete profileof hema.to
ESy-Labs GmbH, based in Regensburg, was founded in 2018 and operates at the interface between the energy and chemical industries. With electrosynthesis as its central technology, ESy-Labs is working towards …
To the complete profileof ESy-Labs
EEDEN starts upcycling – turning textile waste into valuable ressources for new fibres. The Company developed a chemical upcycling process for textile waste, recovering its resources. In this way, new, …
To the complete profileof EEDEN
Nebula Biocides GmbH was founded in 2019 as a spin-off from the Leibniz Institute for Plasma Science and Technology (INP) by the scientists Dr. Jörn Winter, Dr. Ansgar Schmidt-Bleker and …
To the complete profileof Nebula Biocides
LignoPure GmbH is a spin-off of the TU Hamburg that enables the valorization of Lignin, a byproduct of ethanol biorefineries and the pulp and paper industry, via a proprietary technology. …
To the complete profileof LignoPure
Plasmion GmbH developed an „electronic nose sensor” based on mass spectrometry. This technology is not only revolutionizing chemical analysis in the laboratory environment, but is also intended to provide its …
To the complete profileof Plasmion
i3 Membrane is a companion for filtration solutions and separation technologies in life science. With and for the customers, high-quality products in the fields of medical, lab / pharma and …
To the complete profileof i3 Membrane
Guided to exit
Exit
The founders of Kumovis GmbH have set themselves the goal of enabling the additive production of plastic implants and are developing innovative 3D printers specifically for medical products. Kumovis focuses …
To the complete profileof Kumovis
Recent posts
Zum Artikel
German digital medtech startup hema.to receives €3.6 million investment from LUMO Labs and Bayern Kapital for AI-based blood data analysis.
Zum Artikel
Breathing through the gut: MedTech startup O11 biomedical secures EIC Accelerator Grant and seed funding to accelerate growth.
Zum Artikel
Breakthrough for an Alternative to Crude Oil & Palm Oil: COLIPI Receives €1.8 Million Seed Funding for Further Development of CO2-Neutral Climate OilTM
Zum Artikel
Social Media & contact
LinkedIn
Dr. Nikolaus Raupp
Profil